Want to see QSI full AI Analyst Report?
QSI Stock Chart & Stats
$0.77
$0.01(1.73%)
At close: 4:00 PM EDT
$0.77
$0.01(1.73%)
Day’s Range― - ―
52-Week Range$0.69 - $3.10
Previous Close$0.78
Volume1.09M
Average Volume (3M)4.29M
Market Cap
$155.13M
Enterprise Value$43.92
Total Cash (Recent Filing)$127.34M
Total Debt (Recent Filing)$3.71M
Price to Earnings (P/E)―
Beta3.13
Next Earnings
Aug 13, 2026EPS Estimate
-0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.51
Shares Outstanding197,822,660
10 Day Avg. Volume2,470,082
30 Day Avg. Volume4,290,829
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)0.99
Price to Sales (P/S)89.30
P/FCF Ratio-2.24
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$2.50Price Target Upside224.68% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.43
Revenue Forecast (FY)$1.03M
Bulls Say, Bears Say
Bulls Say
Cash Runway Into 2028A cash balance of ~$190M and management's guidance for ≤$93M total cash usage in 2026 provide a multi-year runway into 2028. This durable liquidity cushions R&D and commercialization timelines, reducing near-term financing pressure while allowing continued product de‑risking and scale-up.
Technology De-risking (Proteus)A successfully completed end-to-end Proteus sequencing milestone materially reduces core technical risk ahead of commercial launch. Demonstrated automation and integrated workflows increase the likelihood that instruments will perform in customer labs, a structural prerequisite for sustainable instrument and consumable revenue.
Improved Platform PerformanceSubstantially longer read lengths and higher throughput are durable performance advantages that can increase scientific utility versus incumbents. Higher information per run supports competitive differentiation, stronger lab adoption, and greater consumable pull‑through over time if reproducible at scale.
Bears Say
Very Low And Declining RevenueTop-line is minimal (Q1 revenue $258k; 2026 guide ~$1M) and TTM revenue declined materially. A tiny revenue base limits ability to cover fixed costs, lengthens the path to breakeven, and leaves commercialization largely dependent on future product adoption, not current recurring demand.
High Sustained Cash BurnOperating cash outflows near $90–95M annually create structural funding requirements. Even with a healthy cash balance, persistent negative operating and free cash flow mean the company must manage burn tightly or raise capital, which can dilute shareholders and distract management from long‑term execution.
Commercialization & Scale-up RelianceThe business outlook depends heavily on a timely Proteus launch and effective manufacturing scale‑up. Execution risk around instrument assembly, long‑lead parts, and uncertain customer conversion timing means product advances may not translate into predictable revenue growth over the medium term.
Quantum-Si News
QSI FAQ
What was Quantum-Si’s price range in the past 12 months?
Quantum-Si lowest stock price was $0.69 and its highest was $3.10 in the past 12 months.
What is Quantum-Si’s market cap?
Quantum-Si’s market cap is $155.13M.
When is Quantum-Si’s upcoming earnings report date?
Quantum-Si’s upcoming earnings report date is Aug 13, 2026 which is in 11 days.
How were Quantum-Si’s earnings last quarter?
Quantum-Si released its earnings results on May 07, 2026. The company reported -$0.1 earnings per share for the quarter, beating the consensus estimate of -$0.11 by $0.01.
Is Quantum-Si overvalued?
According to Wall Street analysts Quantum-Si’s price is currently Undervalued.
Does Quantum-Si pay dividends?
Quantum-Si does not currently pay dividends.
What is Quantum-Si’s EPS estimate?
Quantum-Si’s EPS estimate is -0.11.
How many shares outstanding does Quantum-Si have?
Quantum-Si has 197,822,660 shares outstanding.
What happened to Quantum-Si’s price movement after its last earnings report?
Quantum-Si reported an EPS of -$0.1 in its last earnings report, beating expectations of -$0.11. Following the earnings report the stock price went down -7.551%.
Which hedge fund is a major shareholder of Quantum-Si?
Currently, no hedge funds are holding shares in QSI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Quantum-Si Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.50 (224.68% Upside)
$2.50 (224.68% Upside)
Hedge Fund Trend
Decreased
By 144.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $70.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▲ 1.9%
Last 30 Days ▼ 1.1%
Last 30 Days ▼ 1.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-61.11%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-21.34%
Trailing 12-Months
Company Description
Quantum-Si
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.
QSI Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized materially de-risking technical progress for the Proteus platform (successful integrated sequencing, increased amino acid detection, doubled read lengths, PTM strategy) and showed strong early customer engagement and a solid cash runway (~$190M) that supports development through launch. However, near-term revenue remains very small ($258k Q1; ~ $1M outlook for 2026), and the company faces significant R&D/commercialization spend and execution required to scale manufacturing and convert interest into sales. On balance, the advances on Proteus and financial runway are compelling positives, while near-term commercial and burn risks merit monitoring.View all QSI earnings summariesQSI Stock 12 Month Forecast
Average Price Target
$2.50
▲(224.68% Upside)
Technical Analysis
Ownership Overview
22.72% Insiders
6.89% Mutual Funds
2.36% Other Institutional Investors
59.04% Public Companies and
Individual Investors